PDT Partners’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

PDT Partners’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-68,868	Closed	-$1.76M	–	565
2018 Q2	$1.76M	Sell	68,868 -16,053	-19%	-$374K	0.07%	274
2018 Q1	$1.71M	Sell	84,921 -143,435	-63%	-$3.35M	0.06%	297
2017 Q4	$4.58M	Buy	228,356 +963	+0.4%	+$18.9K	0.13%	196
2017 Q3	$4.71M	Buy	227,393 +116,606	+105%	+$1.97M	0.16%	185
2017 Q2	$1.64M	Buy	+110,787	New	+$1.85M	0.07%	278
2015 Q4	–	Sell	-55,990	Closed	-$1.61M	–	1114
2015 Q3	$1.61M	Buy	55,990 +40,986	+273%	+$1.75M	0.04%	544
2015 Q2	$671K	Sell	15,004 -21,983	-59%	-$827K	0.02%	875
2015 Q1	$1.28M	Buy	+36,987	New	+$1.01M	0.03%	675

Other funds holding DPLO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

PDT Partners's DPLO Position: Q3 2018 in Review

PDT Partners sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q3 2018, closing a stake of 68,868 shares — an estimated $1.76M sold.

PDT Partners first reported a position in DPLO in Q1 2015 and held it in 8 quarters. The position peaked at $4.71M in Q3 2017. 178 funds tracked by Wall St. Rank hold DPLO as of Q3 2018.

PDT Partners reported no remaining DIPLOMAT PHARMACY, INC. position as of Q3 2018 after selling out during the quarter.
PDT Partners sold 68,868 DIPLOMAT PHARMACY, INC. shares in Q3 2018, an estimated $1.76M.
PDT Partners first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2015 and held it in 8 quarters.
PDT Partners's DIPLOMAT PHARMACY, INC. position peaked at $4.71M in Q3 2017.
178 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q3 2018.

Based on PDT Partners's 13F filing for Q3 2018, filed 14 Nov 2018.